CANDIDA SPECIES FROM HUMAN MUCOSAL SURFACES: PREVALENCE, VIRULENCE FACTORS AND SUSCEPTIBILITY TO ITRACONAZOLE

Akinjogunla, O. J. and Eghafona, N.O. (2012). Mycological investigation in patients with AOM. Scientific Journal of Microbiology 1(1):19-26.

Akinjogunla, O. J., Divine-Anthony, O. Akpan, M.M. and Ogbonna, F.C. (2019). Virulence markers and antifungal susceptibility of vaginal yeast isolates from contraceptive and non-contraceptive users in Uyo, Nigeria. Journal of Experimental Research, 7(1): 33- 40.

Akinjogunla, O. J., Divine-Anthony, O., Ajayi, A. O., Etukudo, I. U. and Etok, I. J. (2020). Candiduria in Patients with Diabetic Type 1 and 2: Sociodemographic and Risk factors, prevalence, virulence factors and antifungal susceptibility, Journal of Pure and Applied Microbiology, 14(2):1467-1478.

Akinjogunla, O. J., Umo, A. N., Alozie, M. F., Oshosanya, G.O., and Saturday, G. I. (2021). Antibacterial potentiality and time kill kinetics of amlodipine, thioridazine and promethazine against pathogenic bacterial isolates from clinical samples. African Journal of Clinical and Experimental Microbiology, 22 (3): 397 - 406.

Akinjogunla, O.J., Ajayi, A.O. and Nkanga, I.E. (2018). Characterization, in-vitro detection of extracellular hydrolytic enzymes and antifungal susceptibility of faecal Candida isolates from diarrhoeal patients. Nigerian Journal of Pharmaceutical and Applied Science Research. 7:8-14.

Akinjogunla, O.J., Divine-Anthony, O. and Nwadialor, J. (2017). Candida isolates from high vaginal swabs of women of child bearing age: species distributions, virulence factors and antifungal susceptibility profile, Nigerian Journal of Scientific Research, 16 (4): 50-58.

Back-Brito, G.N., Mota, A.J., Vasconcellos, T.C., Querido, S.M.R., Jorge, A.O.C., Reis, A.S.M., Balducci, C.Y. and Koga-Ito, I. (2009). Frequency of Candida spp. in the oral cavity of Brazilian HIV-positive patients and correlation with CD4 cell counts and viral load. Mycopathologia. 167: 81-87.

Badiee, P. and Alborzi, A. (2011). Susceptibility of clinical Candida species isolates to antifungal agents by E-test, Southern Iran: a five year study. Iranian Journal Microbiology 3(4):183188.

Badiee, P., Badali, H. and Boekhout, T. (2017). Antifungal susceptibility testing of Candida species isolated from the immunocompromised patients admitted to ten university hospitals in Iran: comparison of colonizing and infecting isolates. BMC Infectious Diseases 17: 727.730.

Barnett, H.L. and Hunter, B.B. (1987). Illustrated Genera of Imperfect Fungi. 4th edn, McMillian, New York. 1987. 218 p.

Butola, R., Agwan, V., Thakuria, B. and Madan, M. (2015). A comparative study of virulence factors in clinical isolates of Candida species. International Journal of Current Microbiology and Applied Sciences. 4:716-722.

Calderone, R.A. (2002). Introduction and historical perspectives. Candida and Candidiasis (Calderone R., ed), ASM Press, Washington, DC. pp. 1525.

Clinical Laboratory Standards Institute (2015). Method for antifungal disk diffusion Susceptibility testing of Yeasts; Approved Guideline-(4 Ed). CLSI document M44-A2. Clinical Laboratory Standard Institute, Wayne: Pennsylvania.

DaCosta, K.R., Ferreira, J.C., Komesu, M.C. and Candido, R.C. (2009). Candida albicans and Candida tropicalis in oral candidiasis: quantitative analysis, exoenzyme activity, and antifungal drug sensitivity. Mycopathologia, 167(2): 1-6.

Deorukhkar, S.C., Santosh, S. and Stephen M. (2014). Non-albicans Candida Infection: An Emerging Threat. Interdisciplinary Perspectives on Infectious Diseases. Article ID 615958.

Houang, E.T.S., Chu, K.C., Koehler, A.P. and Cheng, A.F.B. (1997). Use of CHROMagar Candida for genital specimens in the diagnostic laboratory. Clinical Pathology. 50: 563-565.

Manns, J.M., Mosser, D.M. and Buckley, H.R. (1994). Production of a haemolytic factor by Candida albicans. Infection and Immunology, 62: 51545156.

Marak, M.B and Dhanashree, B. (2018). Antifungal susceptibility and biofilm production of candida spp. isolated from clinical samples. International Journal of Microbiology. 1-5. Article ID 7495218.

Martins, C.A.D., Koga-Ito, C.Y. and Jorge, A.O.C. (2002). Presence of Staphylococcus spp. and Candida spp. in the human oral cavity. Brazilian Journal of Microbiology. 33:236-240.

Mba, I.E. and Nweze, E.I. (2019). Antifungal resistance profile and enzymatic activity of Candida species recovered from human and animal samples. Bio-Research. 17 (1); 1044-1055.

McGinnis, M.R. and Rinaldi, M.G. (1996). Antifungal drugs: mechanisms of action, drug resistance, susceptibility testing and assays of activity in biological fluids. In: Antibiotics in laboratory medicine. Lorain V, editor. Baltimore: Williams & Wilkins, pp. 176-211.

Mohandas, V. and Ballal, M. (2011). Distribution of Candida species in different clinical samples and their virulence: biofilm formation, proteinase and phospholipase production: a study on hospitalized patients in southern India. Journal of Global Infectious Diseases. 3(1):4-8.

Nastri, M.L., Hecht, P., Nastri, N., Jewtuchowicz, V., Cuesta, A., Estrugo, J., Gualtieri, A., Sordelli, D.O. and Rosa, A. (2012). Nasal carriage of Staphylococcus aureus and Candida species in immunocompetent individuals. Acta Odontol Latinoam. 25(3):324-329.

Nweze, E.I. and Ogbonnaya, U.L. (2011). Oral Candida isolates among HIV-infected subjects in Nigeria. Journal of Microbiology, Immunology and Infection. 44:172-177.

Okon, M. U., Akinjogunla, O. J., Akang, I.A., Akaka, B. C. and Umoh, M.I. (2020). Logarithmic and percentage reductions of bacterial isolates in G. paradoxa treated with C. aurantifolia and sodium chloride: public health implication and nutritional assessment. FUDMA Journal of Science, 4 (3): 406 - 415.

Pandey, N., Gupta, M.K. and Tilak, R. (2018). Extracellular hydrolytic enzyme activities of the different Candida spp. isolated from the blood of the intensive care unit-admitted patients. Journal of Laboratory Physicians. 10:4.

Paula, C.R., Sampaio, M.C., Birman, E.G. and Siqueira, A.M. (1990). Oral yeasts in patients with cancer of the mouth, before and during radiotherapy. Mycopathologia, 112: 119-124.

Pfaller, M.A and Diekema, D.J. (2012). Progress in antifungal susceptibility testing of Candida spp by use of clinical and laboratory standards institute broth microdilution methods, 2010 to 2012. Journal of Clinical Microbiology. 50(9):28462856.

Rafat, Z., Hashemi, S.J. and Ahamdikia, K. (2017). Study of skin and nail Candida species as a normal flora based on age groups in healthy persons in Tehran-Iran. Journal of Medical Mycology. 27(4): 501505.

Rossoni, R.D., Barbosa, J.O., Vilela, S.F., Jorge, A.O. and Junqueira, J.C. (2013). Comparison of the hemolytic activity between C. albicans and non-albicans Candida species. Brazilian Oral Research. 27(6):484-489.

Samaranayake, L.P. and MacFarlane, T.W. (1990). Oral Candidiasis. Wright Butterworth, London, UK. pp 122-134.

Sardi, J.C.O., Scorzoni, L.T., Bernardi, A.M., Fusco-Almeida, M. and Giannini, M.J.S. (2013). Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. Journal of Medical Microbiology. 62(Pt 1):10-24.

Schaller, M., Borelli, C., Korting, H.C. and Hube, B. (2005). Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses. 48:365-377.

Silva, S., Negri, M., Henriques, M., Oliveira, R., David W.W. and Azeredo, J. (2011). Adherence and biofilm formation of non-Candida albicans species. Trends in Microbiology, 19(5): 241-247.

Sun, J., Cheng, Q. C., Lafleur, M.D. and Qi1, Q. (2009). Fluconazole susceptibility and genotypic heterogeneity of oral Candida albicans colonies from the patients with cancer receiving chemotherapy in China. International Journal of Oral Science. 1(3): 156162

Tsang, C.S., Chu, F.C., Leung, W.K., Jin, L.J., Samaranayake, L.P. and Siu, S.C. (2007). Phospholipase, proteinase and haemolytic activities of Candida albicans isolated from oral cavities of patients with type 2 diabetes mellitus. Journal of Medical Microbiology. 56(10): 13931398.

Ying, S. and Chunyang, L. (2012). Correlation between phospholipase of Candida albicans and resistance to fluconazole. Mycoses, 55(1):5055.